26 May 2013
Keywords: positive, results, ista, bepreve, firm, pharmaceuticals, announced
Article | 12 May 2008
US firm ISTA Pharmaceuticals has announced positive preliminary results from the second Phase III trial on its candidate Bepreve (bepotastine
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 April 2008
24 May 2013
© 2013 thepharmaletter.com